What is LetsGetChecked?
LetsGetChecked operates as a medical technology platform, bridging the gap between consumers and a global network of laboratories for accessible at-home health testing. Headquartered in New York, NY, the company leverages technology to provide convenient and reliable health diagnostics. Its business model focuses on empowering individuals with health insights through a connected ecosystem of testing services and laboratory partnerships, positioning it as a key player in the digital health and diagnostics market.
How much funding has LetsGetChecked raised?
LetsGetChecked has raised a total of $263M across 4 funding rounds:
Series A
$12M
Series C
$71M
Series B
$30M
Series D
$150M
Series A (2018): $12M with participation from Optum Ventures
Series B (2020): $30M, investors not publicly disclosed
Series C (2020): $71M supported by Illumina Ventures, CommonFund Capital, Deerfield, Angeles Investments, Optum Ventures, Transformation Capital, HLM Venture Partners, and Qiming Venture Partners USA
Series D (2021): $150M featuring Casdin Capital
Key Investors in LetsGetChecked
Illumina Ventures
Illumina Ventures is a venture capital firm specializing in genomics and precision health, aiming to accelerate innovation in life sciences and healthcare. They support companies developing advanced diagnostics, biopharmaceuticals, and gene editing technologies.
Deerfield
Deerfield Management is an investment firm dedicated to advancing healthcare through strategic investments and data-driven innovation. They focus on companies across the healthcare ecosystem, utilizing AI and market research to foster advancements.
Optum Ventures
Optum Ventures is an investment arm focused on improving healthcare by backing early-stage companies that are disrupting the status quo. They invest in innovative solutions poised to transform the health sector.
What's next for LetsGetChecked?
The substantial enterprise-level funding LetsGetChecked has attracted indicates a strategic phase of scaling and market expansion. This capital infusion is likely to fuel further development of its platform, enhancement of its laboratory network, and broader market penetration. The company is poised to capitalize on the growing demand for convenient and personalized health solutions, potentially exploring new testing modalities and strengthening its global reach. Continued investment in technology and strategic partnerships will be crucial for maintaining its competitive edge and driving future growth in the rapidly evolving health-tech landscape.
See full LetsGetChecked company page
